Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast Reconstruction
Case Control Study to Evaluate the Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast Reconstruction
1 other identifier
observational
300
1 country
1
Brief Summary
The investigators intend to undertake a study to investigate the effect of radiotherapy on deep inferior epigastric perforator flap reconstructions (DIEP). Adjuvant post-mastectomy radiotherapy (PMRT) is offered to women at high risk of chest wall recurrence. The perceived detrimental effect of radiotherapy on an immediate breast reconstruction and the "one-off" nature of autologous reconstruction leads some surgeons to recommend delayed reconstruction after mastectomy or to use a temporising implant with a view to planned exchange to autologous reconstruction after radiotherapy. However, there remains significant uncertainty in the literature about the impact of radiotherapy on autologous reconstructions. This study is a mixed methology study using patient reported outcome measures (PROMS), applanation tonometry (measure of breast compressibility), semi-structured interviews and 3 dimensional photography analysis to compare the aesthetic and impact on quality of life on the following groups of patients: Patient groups:
- 1.Unilateral skin sparing mastectomy (SSM) with immediate DIEP flap reconstruction and PMRT (cases)
- 2.Unilateral SSM with immediate DIEP flap reconstruction and no PMRT (controls)
- 3.Unilateral simple mastectomy, PMRT, and subsequent delayed DIEP flap reconstruction (controls)
- 4.Unilateral SSM with temporizing implant, PMRT and subsequent conversion to DIEP (controls)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2015
CompletedStudy Start
First participant enrolled
January 14, 2016
CompletedFirst Posted
Study publicly available on registry
March 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 14, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 14, 2018
CompletedApril 4, 2017
March 1, 2017
2 years
April 13, 2015
March 31, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The difference in patient satisfaction score between patients with an irradiated DIEP flap (group (a)) and patients with a DIEP flap who have not undergone PMRT (group (b)) using "satisfaction with reconstructed breast" question of the BREAST-Q.
The difference in (mean or median) patient satisfaction score (ranging from 0-100) between patients with an irradiated DIEP flap (group (a)) and patients with a DIEP flap who have not undergone PMRT (group (b)) using the "satisfaction with reconstructed breast" subscale of the postoperative reconstruction module of the BREAST-Q questionnaire.
Day 1
Secondary Outcomes (11)
The difference in scores in other subscales from the BREAST-Q questionnaire between patients with an irradiated DIEP flap (group (a)) and patients with a DIEP flap who have not undergone PMRT (group (b)).
Day 1
The difference in patient satisfaction and all subscales between patients with an irradiated DIEP flap (group (a)) and patients who underwent PMRT prior to DIEP flap (group (c) and group (d)) using BREAST-Q scores as above.
Day 1
Volume and symmetry assessment of the reconstructed breast using 3D surface imaging This would consist of comparing volume and symmetry assessment between groups (a) and (b), groups (a) and (c), and groups (a) and (d).
Day 1
Panel assessment by independent panel of the reconstruction using 3D surface imaging.
Day 1
Applanation tonometry for assessment of the consistency of the reconstructed breast. This will consist of comparing breast compressibility in the reconstructed breast between groups (a) and (b), groups (a) and (c), and groups (a) and (d).
Day 1
- +6 more secondary outcomes
Study Arms (4)
SSM immediate DIEP
Unilateral skin sparing mastectomy with immediate DIEP
SSM immediate DIEP and PMRT
Unilateral skin sparing mastectomy with immediate DIEP flap reconstruction and post mastectomy radiotherapy
mastectomy, PMRT, delayed DIEP
simple mastectomy, post mastectomy radiotherapy adn then delayed DIEP reconstruction
SSM, temporizing implant, PMRT then DIEP
Unilateral SSM with temporizing implant, PMRT and subsequent
Interventions
3D photography
qualitative analysis using semi structured interview
measurement of breast compressibility
Eligibility Criteria
Any patient who has undergone unilateral DIEP reconstruction for breast cancer at the Royal Marsden NHS Foundation Trust
You may qualify if:
- Women who have undergone one of the treatment sequences above (a) - (d)
- Patient groups:
- Unilateral skin sparing mastectomy (SSM) with immediate DIEP flap reconstruction and PMRT (cases)
- Unilateral SSM with immediate DIEP flap reconstruction and no PMRT (controls)
- Unilateral simple mastectomy, PMRT, and subsequent delayed DIEP flap reconstruction (controls)
- Unilateral SSM with temporizing implant, PMRT and subsequent conversion to DIEP (controls)
- Patients of any age will be included
- Patients who are between one and five years post initial breast reconstruction surgery or radiotherapy (which ever is most recent)
You may not qualify if:
- Women who have undergone bilateral mastectomy, even if the contralateral mastectomy was asynchronous.
- Women who are less than one year from their last radiotherapy treatment or from their DIEP flap reconstruction.
- Patients who have had more than one implant based operation before DIEP flap (revision surgery to the implant implies that an implant based reconstruction was the primary intent and therefore the DIEP flap is a 'salvage' procedure) or if it is documented to be a salvage reconstruction.
- Women who have developed recurrent / distant disease.
- Women who are unable to stand for the 3D imaging (approximately 10 minutes)
- Women who are unable to complete the English language questionnaire or interview (i.e. learning difficulties or patients who do not have adequate English language skills).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Royal Marsden NHS Foundation Trust
London, London, SW3 6JJ, United Kingdom
Related Publications (1)
O'Connell RL, Di Micco R, Khabra K, Kirby AM, Harris PA, James SE, Power K, Ramsey KWD, Rusby JE. Comparison of Immediate versus Delayed DIEP Flap Reconstruction in Women Who Require Postmastectomy Radiotherapy. Plast Reconstr Surg. 2018 Sep;142(3):594-605. doi: 10.1097/PRS.0000000000004676.
PMID: 29927832DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Rusby, DM FRCS
The Royal Marsden Hospital NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2015
First Posted
March 7, 2017
Study Start
January 14, 2016
Primary Completion
January 14, 2018
Study Completion
January 14, 2018
Last Updated
April 4, 2017
Record last verified: 2017-03